Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer
by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh
Updated on: February 20,2024
14

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer
by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh
Updated on:February 20,2024
14
